Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert's and patient's perspective.

Jonaitis L, Marković S, Farkas K, Gheorghe L, Krznarić Ž, Salupere R, Mokricka V, Spassova Z, Gatev D, Grosu I, Lijović A, Mitrović O, Saje M, Schafer E, Uršič V, Roblek T, Drobne D

Open source

DOI
10.1186/s12919-021-00230-7
Published
2021 Dec 9
Container
BMC proceedings
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12919-021-00230-7,
  title = {Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert's and patient's perspective.},
  author = {Jonaitis L and Marković S and Farkas K and Gheorghe L and Krznarić Ž and Salupere R and Mokricka V and Spassova Z and Gatev D and Grosu I and Lijović A and Mitrović O and Saje M and Schafer E and Uršič V and Roblek T and Drobne D},
  year = {2021},
  journal = {BMC proceedings},
  doi = {10.1186/s12919-021-00230-7},
  url = {https://doi.org/10.1186/s12919-021-00230-7}
}

RIS

TY  - JOUR
TI  - Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert's and patient's perspective.
AU  - Jonaitis L
AU  - Marković S
AU  - Farkas K
AU  - Gheorghe L
AU  - Krznarić Ž
AU  - Salupere R
AU  - Mokricka V
AU  - Spassova Z
AU  - Gatev D
AU  - Grosu I
AU  - Lijović A
AU  - Mitrović O
AU  - Saje M
AU  - Schafer E
AU  - Uršič V
AU  - Roblek T
AU  - Drobne D
PY  - 2021
JO  - BMC proceedings
DO  - 10.1186/s12919-021-00230-7
UR  - https://doi.org/10.1186/s12919-021-00230-7
ER  - 

APA

L, J., S, M., K, F., L, G., Ž, K., R, S., V, M., Z, S., D, G., I, G., A, L., O, M., M, S., E, S., V, U., T, R., & D, D. (2021). Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert's and patient's perspective.. BMC proceedings. https://doi.org/10.1186/s12919-021-00230-7

Source records